Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,774
Total Claims
$1.8M
Drug Cost
355
Beneficiaries
$5,174
Cost/Patient
Risk Score Breakdown 35/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,186 Anesthesiology providers
+8%
Opioid rate vs peers
37.6% vs 34.8% avg
+1126%
Cost per patient vs peers
$5,174 vs $422 avg
+177%
Brand preference vs peers
13.1% vs 4.7% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Cost per patient is 1126% above the specialty average. Extreme cost outliers may indicate prescribing of unnecessarily expensive brand-name drugs or inappropriate drug utilization.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
37.6%
Opioid Rate
4,431
Opioid Claims
$1.1M
Opioid Cost
44.3%
Long-Acting Rate
This provider's opioid prescribing rate of 37.6% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 1,535 claims · $1.4M
Generic: 10,190 claims · $481K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 246 | $291K |
| Oxycodone Hcl | 200 | $250K |
| Buprenorphine | 52 | $110K |
| Buprenorphine Hcl/Naloxone Hcl | 78 | $95K |
| Buprenorphine Hcl | 94 | $80K |
| Tapentadol Hcl | 50 | $65K |
| Buprenorphine | 186 | $60K |
| Buprenorphine Hcl/Naloxone Hcl | 245 | $54K |
| Rimegepant Sulfate | 34 | $54K |
| Tapentadol Hcl | 27 | $51K |
| Oxymorphone Hcl | 39 | $50K |
| Oxycodone Hcl | 51 | $44K |
| Ubrogepant | 26 | $37K |
| Fentanyl | 201 | $37K |
| Linaclotide | 63 | $36K |
Prescribing Profile
109
Unique Drugs
35.0
Anomaly Score
Patient Profile
67
Avg Age
61%
Female
1.75
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About